Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.

acute myeloid leukemia allogeneic hematopoietic stem cell transplantation chemotherapy glutamate oxaloacetate transaminase 1 prognosis

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 15 07 2019
accepted: 04 03 2020
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 9 4 2020
Statut: epublish

Résumé

One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and apoptosis by regulating cell's metabolic dependency on glucose. It is unclear whether the expression level of

Identifiants

pubmed: 32266153
doi: 10.3389/fonc.2020.00379
pmc: PMC7105742
doi:

Types de publication

Journal Article

Langues

eng

Pagination

379

Informations de copyright

Copyright © 2020 Cheng, Dai, Zeng, Liu, Cui, Qian, Si, Huang, Pang, Ye, Shi and Fu.

Références

Blood Rev. 2017 Jan;31(1):63-76
pubmed: 27639498
Am J Med Sci. 2015 Nov;350(5):369-73
pubmed: 26517501
Mol Biol Cell. 2004 Jun;15(6):2523-36
pubmed: 15034139
Cancer Lett. 2017 Aug 1;400:37-46
pubmed: 28455244
Cell Metab. 2008 Jan;7(1):11-20
pubmed: 18177721
Haematologica. 2011 Sep;96(9):1284-92
pubmed: 21606170
Cancer Metab. 2015 Oct 12;3:12
pubmed: 26462257
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
N Engl J Med. 2015 Sep 17;373(12):1136-52
pubmed: 26376137
Annu Rev Med. 2016;67:59-72
pubmed: 26473413
Free Radic Biol Med. 2011 Dec 1;51(11):1943-51
pubmed: 21964034
Cancer. 2016 Nov 15;122(22):3484-3491
pubmed: 27463065
Cell Physiol Biochem. 2018;47(5):1853-1861
pubmed: 29961066
Semin Cancer Biol. 2015 Dec;35 Suppl:S129-S150
pubmed: 26454069
N Engl J Med. 2012 Mar 22;366(12):1079-89
pubmed: 22417203
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18782-7
pubmed: 19033189
Blood. 2010 Sep 16;116(11):1839-48
pubmed: 20538804
Cancer Gene Ther. 2018 May;25(3-4):77-83
pubmed: 29491461
Cancer Gene Ther. 2019 Sep;26(9-10):305-312
pubmed: 30348947
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Gastroenterology. 2016 Nov;151(5):945-960.e6
pubmed: 27451147
Nature. 2013 Apr 4;496(7443):101-5
pubmed: 23535601
Cancer Gene Ther. 2019 Feb;26(1-2):17-25
pubmed: 29910468
J Clin Oncol. 2012 Sep 1;30(25):3109-18
pubmed: 22753902
J Clin Oncol. 2012 Mar 1;30(7):742-50
pubmed: 22291079
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2675-2678
pubmed: 29731362
BMC Cancer. 2018 May 11;18(1):559
pubmed: 29751795

Auteurs

Zhiheng Cheng (Z)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Yifeng Dai (Y)

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Tiansheng Zeng (T)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Yan Liu (Y)

Translational Medicine Center, Huaihe Hospital of Henan University, Kaifeng, China.

Longzhen Cui (L)

Translational Medicine Center, Huaihe Hospital of Henan University, Kaifeng, China.

Tingting Qian (T)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Chaozeng Si (C)

Department of Operations and Information Management, China-Japan Friendship Hospital, Beijing, China.

Wenhui Huang (W)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Ying Pang (Y)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Xu Ye (X)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Jinlong Shi (J)

Department of Biomedical Engineering, Chinese PLA General Hospital, Beijing, China.

Lin Fu (L)

Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Hematology, Huaihe Hospital of Henan University, Kaifeng, China.

Classifications MeSH